Bioxytran, Inc
BIXT· OTC
BIXTBioxytran, Inc
Filed Mar 18, 2020 · 10-K · 78 days after period end · 0001213900-20-006766
derived · Computed from the longer spans the company filed.
| Metric | Q4 2019dderived from reported figures | Q4 2017 | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $32.19K | $58.20K | $23.15K |
| Net Income | -$662.66K | -$86.41K | $135.28K | -$351.32K |
| EPS Diluted | — | $0.00 |
Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR
| — |
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2019 · filed Mar 18, 2020 · 78 d after period end
